Literature DB >> 8117743

Differential effect of growth- and differentiation-inducing factors on the release of eicosanoids and phospholipids from ML-1 human myeloblastic leukemia cells.

H Wikiel1, L Zhao, T Gessner, A Bloch.   

Abstract

In the absence of serum, growth of ML-1 human myeloblastic leukemia cells is induced by the insulin-like growth factor-1 (IGF1) together with transferrin (Tf), whereas monocytic differentiation is initiated by the transforming growth factor-beta (TGF-beta) in combination with Tf. Initiation of growth was followed by the rapid release of arachidonic acid (AA), hydroxyeicosatetraenoic acids (HETEs) and phospholipids into the culture medium. In contrast, induction of differentiation occurred without the release of these lipids beyond the level present in control. Inhibitors of enzymes involved in the formation of AA and of HETEs, including phospholipase A2 and lipoxygenases, caused interference with growth but not with differentiation, and an inhibitor of the cyclooxygenase path affected neither growth nor differentiation. These results indicate that the initiation of ML-1 cell growth but not of cell differentiation is dependent upon the increased formation of AA and its derivatives formed primarily via the lipoxygenase path.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8117743     DOI: 10.1016/0005-2760(94)90265-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Sphingomyelinase activity of Trichomonas vaginalis extract and subfractions.

Authors:  Francisco González-Salazar; Jesús N Garza-González; Carlos E Hernandez-Luna; Benito David Mata-Cárdenas; Pilar Carranza-Rosales; Jorge Enrique Castro-Garza; Magda Elizabeth Hernández-García; Javier Vargas-Villarreal
Journal:  Biomed Res Int       Date:  2013-08-19       Impact factor: 3.411

2.  Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism.

Authors:  Rasha Hammamieh; Dena Sumaida; XiaoYan Zhang; Rina Das; Marti Jett
Journal:  BMC Cancer       Date:  2007-07-25       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.